Multiple sclerosis: three trials to watch
Following ECTRIMS 2025, Clinical Trials Arena explores the potential of some major Phase III assets in MS.
28 October 2025
28 October 2025
Following ECTRIMS 2025, Clinical Trials Arena explores the potential of some major Phase III assets in MS.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.